While Russia may have become the first country in the world to grant regulatory approvals toits COVID-19 vaccine, the accelerated rate at which the vaccine has been developed has been raising eyebrows. Dr Randeep Guleria, the director of All India Institute for Medical Sciences echoed similar sentiments. He underlined that it is crucial to check the safety and efficacy of the Russian vaccine candidate. He also said that India has the capacity for mass production of the vaccine.
In an interview with Hindustan Times, Dr Guleria said, “If Russia’s vaccine is successful, then we will have to see critically whether it is safe and effective. There should not be any side effects of the vaccine and it should provide good immunity and protection. India has the capacity for mass production of the vaccine.
